MY202113A - Enterovirus 71 animal model - Google Patents

Enterovirus 71 animal model

Info

Publication number
MY202113A
MY202113A MYPI2017001107A MYPI2017001107A MY202113A MY 202113 A MY202113 A MY 202113A MY PI2017001107 A MYPI2017001107 A MY PI2017001107A MY PI2017001107 A MYPI2017001107 A MY PI2017001107A MY 202113 A MY202113 A MY 202113A
Authority
MY
Malaysia
Prior art keywords
enterovirus
animal model
relates
present
vpl
Prior art date
Application number
MYPI2017001107A
Inventor
Kaw Bing Chua
Original Assignee
Temasek Life Sciences Laboratory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Temasek Life Sciences Laboratory Ltd filed Critical Temasek Life Sciences Laboratory Ltd
Publication of MY202113A publication Critical patent/MY202113A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0337—Animal models for infectious diseases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32371—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Environmental Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)

Abstract

The present invention relates to Enterovirus 71 (EV71), the development of an animal model and screening of candidate anti-EV71 compounds. More specifically, the present invention relates to the discovery that Enterovirus 71 (EV71) strains that have been adapted to infect rodent cell lines or cloned derived virus containing mutations in VPl can cause disease in immuno-competent rodents.
MYPI2017001107A 2015-01-28 2016-01-25 Enterovirus 71 animal model MY202113A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562108828P 2015-01-28 2015-01-28
US201562114880P 2015-02-11 2015-02-11
PCT/SG2016/050031 WO2016122403A1 (en) 2015-01-28 2016-01-25 Enterovirus 71 animal model

Publications (1)

Publication Number Publication Date
MY202113A true MY202113A (en) 2024-04-04

Family

ID=56543857

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2017001107A MY202113A (en) 2015-01-28 2016-01-25 Enterovirus 71 animal model

Country Status (8)

Country Link
JP (1) JP6772155B2 (en)
KR (1) KR20170106473A (en)
CN (1) CN107849540B (en)
AU (1) AU2016212766B2 (en)
MY (1) MY202113A (en)
SG (1) SG11201706054QA (en)
TW (1) TWI764859B (en)
WO (1) WO2016122403A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112094822B (en) * 2019-06-02 2025-10-24 复旦大学 Infectious cDNA cloning based on EV71 strain and its application
KR102243526B1 (en) * 2020-01-21 2021-04-22 (주)노터스생명과학 Transgenic animal for Nonclinical evaluation of Foot and Mouth Disease Vaccine and producing method thereof
US20240043944A1 (en) * 2020-12-21 2024-02-08 Chiaho Shih Novel enterovirus 71 mutations associated with disease severity
CN114304064A (en) * 2021-12-16 2022-04-12 首都医科大学 Method for establishing animal model with head deformity accompanied with nerve-dyskinesia
CN115211402A (en) * 2022-07-07 2022-10-21 中国医学科学院医学生物学研究所 Construction method and application of CV-B3 infected rodent model
CN117143204B (en) * 2023-08-04 2025-11-21 中国医学科学院医药生物技术研究所 Construction and application of enterovirus 71 type VP1 protein 75 th amino acid mutant virus strain
CN119842818A (en) * 2025-03-19 2025-04-18 中国医学科学院医学生物学研究所 Mouse model for infecting coxsackievirus A16 and construction method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102220288B (en) * 2011-05-04 2013-07-17 中国科学院上海巴斯德研究所 Mouse-addapted enterovirus EV71 strain 573 and use thereof

Also Published As

Publication number Publication date
KR20170106473A (en) 2017-09-20
TW201702376A (en) 2017-01-16
NZ734517A (en) 2024-12-20
AU2016212766A1 (en) 2017-09-07
WO2016122403A1 (en) 2016-08-04
CN107849540A (en) 2018-03-27
JP6772155B2 (en) 2020-10-21
AU2016212766B2 (en) 2022-03-24
SG11201706054QA (en) 2017-08-30
CN107849540B (en) 2021-12-21
JP2018513671A (en) 2018-05-31
TWI764859B (en) 2022-05-21

Similar Documents

Publication Publication Date Title
MY202113A (en) Enterovirus 71 animal model
CY1125424T1 (en) NON-HUMAN ANIMALS EXPRESSING HUMANIZED CD3 COMPLEX
MX2022001201A (en) MICE WITH HUMANIZED SIRP¿-IL15 GENES INSERTED AND METHODS TO USE THEM.
Redinbaugh et al. Control of virus diseases in maize
EA201691826A1 (en) METHOD OF USING GRAPHENE AND OTHER TWO-DIMENSIONAL MATERIALS IN VIVO AND IN VITRO
GB2548059A (en) Induced hepatocytes and uses thereof
EA201792663A1 (en) METHODS OF SCREENING BACTERIA, ARCHEAN, ALGAE AND YEAST WITH THE USE OF CRISPR NUCLEIC ACIDS
EA201792420A1 (en) COMPOSITIONS AND METHODS OF TCR REPROGRAMMING BY MEANS OF HYBRID PROTEINS
MX2017004980A (en) Ancestral human genomes.
EA202090548A1 (en) VACCINE FOR USE IN PREVENTION AND / OR TREATMENT OF DISEASE
EP3484510A4 (en) MODIFIED 3C PROTECTS FROM FOOT AND MOUTH DISEASE VIRUS, COMPOSITIONS AND RELATED METHODS
EA201790265A1 (en) METHODS FOR OBTAINING PLATELET-CONTAINING PRODUCTS
IL270876A (en) Novel oncolytic viruses for inducing tumor cell killing by natural killer cells
WO2017048809A8 (en) Nk cells exhibiting an adaptive phenotype and methods for preparing and for using
EA201791416A1 (en) POPULATION OF RPE CELLS AND METHODS TO OBTAIN THEM
EA201691677A1 (en) GENETIC LOCUSES ASSOCIATED WITH INCREASED FERTILITY IN MAIS
NZ752893A (en) Synthetic chimeric poxviruses
EP3717648A4 (en) MODIFIED NOROVIRUS VP1 PROTEINS AND NOROVIRUS VP1 PROTEINS INCLUDING VLPs
MX390053B (en) GENOMIC EVALUATION METHODS IN LIVESTOCK.
Liu et al. Diamond-α weighted Ostrowski type and Grüss type inequalities on time scales
EP3906051A4 (en) ADAPTATION OF ENTEROVIRUS TO VERO CELLS AND VACCINE FORMULATIONS THEREOF
Sahoo et al. Effects of additional food on an ecoepidemic model with time delay on infection
Aggarwal Correlation functions of the Schur process through Macdonald difference operators
DK3194602T3 (en) RELATIONSHIPS AND PROCEDURES TO ENHANCE VIRUS REVERSION TO HUMAN HEMATOPOIETIC CELLS
FR3030523B1 (en) NOVEL COMPOUNDS OF THE N-ACYLAMINO-AMIDE FAMILY, COMPOSITIONS COMPRISING THE SAME, AND USES THEREOF